Refine search

Date
Tumour Site
Topics
Congress

5 results for ""

Challenges in cell-based immunotherapies create opportunities for progress

Challenges in cell-based immunotherapies create opportunities for progress

According to the 2023 ESMO Immuno-Oncology Awardee, Steven A. Rosenberg, the keys to progress are identifying the optimal characteristics of antitumour effector lymphocytes, cancer antigen identification and strategies for overcoming resistance mechanisms to enhance immune-cell function

Editorial_Cell Therapy

TIL therapy – an opportunity for a few centres?

Regulatory, practical and economic challenges are associated with implementing this personalised treatment on a larger scale, thus currently limiting its availability and accessibility to patients

    By
  • Marco Donia

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.